Is Kybella the Next Big Thing? One Surgeon Shares His Insights and Experience with Kybella
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Neothetics expects to file a NDA package for LIPO-202 in the second half of 2016. Stay tuned.
The ISAPS 2025 global survey reports nearly 17.9 million surgical and 17.3 million non-surgical procedures, with eyelid surgery ranking as the most common surgery.